COMMONWEALTH EQUITY SERVICES, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 309 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$309
-13.4%
23,868
-7.1%
0.00%
-100.0%
Q1 2024$357
-12.9%
25,695
-10.6%
0.00%0.0%
Q4 2023$410
-4.0%
28,748
+4.2%
0.00%0.0%
Q3 2023$427
-10.5%
27,596
-9.1%
0.00%0.0%
Q2 2023$477
-16.2%
30,356
-12.2%
0.00%0.0%
Q1 2023$569
+4.0%
34,576
-1.5%
0.00%0.0%
Q4 2022$547
-99.9%
35,106
-46.7%
0.00%
-50.0%
Q3 2022$854,000
-10.5%
65,857
-3.1%
0.00%0.0%
Q2 2022$954,000
-12.4%
67,990
-10.6%
0.00%0.0%
Q1 2022$1,089,000
+0.9%
76,071
-3.9%
0.00%0.0%
Q4 2021$1,079,000
-45.6%
79,174
-34.6%
0.00%
-60.0%
Q3 2021$1,983,000
-30.7%
121,067
-28.8%
0.01%
-28.6%
Q2 2021$2,862,000
+12.9%
170,096
+22.5%
0.01%0.0%
Q1 2021$2,534,000
+43.4%
138,807
+42.9%
0.01%
+40.0%
Q4 2020$1,767,000
+265.8%
97,133
+258.5%
0.01%
+150.0%
Q3 2020$483,000
-10.9%
27,094
-10.4%
0.00%0.0%
Q2 2020$542,000
+12.7%
30,246
-4.7%
0.00%0.0%
Q1 2020$481,000
-31.7%
31,736
-11.1%
0.00%
-33.3%
Q4 2019$704,000
+20.8%
35,695
+5.2%
0.00%
+50.0%
Q3 2019$583,000
+28.7%
33,928
+32.5%
0.00%0.0%
Q2 2019$453,000
-37.4%
25,600
-28.0%
0.00%
-33.3%
Q1 2019$724,00035,5670.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Adelphi Capital LLP 9,270,535$188,841,00039.13%
Sachem Head Capital 5,963,600$121,479,0007.38%
NINE MASTS CAPITAL Ltd 1,049,886$21,415,0006.68%
Paulson & Co. 26,489,422$539,590,0005.77%
Blackcrane Capital, LLC 189,549$3,861,0005.16%
Glenview Capital Management 26,112,660$531,915,0004.75%
Exane Asset Management 430,369$8,766,617,0004.26%
Velanne Asset Management Ltd 281,972$5,744,0003.97%
Bluefin Trading, LLC 1,204,702$24,540,0003.55%
Endurant Capital Management LP 437,436$8,911,0003.52%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders